Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study

Giorgos K Sakkas, Kathleen Mulligan, Makani Dasilva, Julie W Doyle, Hootan Khatami, Thomas Schleich, Jane A Kent-Braun, Morris Schambelan, Giorgos K Sakkas, Kathleen Mulligan, Makani Dasilva, Julie W Doyle, Hootan Khatami, Thomas Schleich, Jane A Kent-Braun, Morris Schambelan

Abstract

Background: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients.

Methodology/principal findings: This is a randomized, double blind, placebo-controlled, clinical research center-based, outpatient study in San Francisco. 40 HIV-positive men (20 creatine, 20 placebo) enrolled in a 14-week study. Subjects were randomly assigned to receive creatine monohydrate or placebo for 14 weeks. Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4.8 g/day or placebo. Beginning at week 2 and continuing to week 14, all subjects underwent thrice-weekly supervised resistance exercise while continuing on the assigned study medication (with repeated 6-week cycles of loading and maintenance). The main outcome measurements included muscle strength (one repetition maximum), energetics ((31)P magnetic resonance spectroscopy), composition and size (magnetic resonance imaging), as well as total body composition (dual-energy X-ray absorptiometry). Thirty-three subjects completed the study (17 creatine, 16 placebo). Strength increased in all 8 muscle groups studied following PRT, but this increase was not augmented by creatine supplementation (average increase 44 vs. 42%, difference 2%, 95% CI -9.5% to 13.9%) in creatine and placebo, respectively). There were no differences between groups in changes in muscle energetics. Thigh muscle cross-sectional area increased following resistance exercise, with no additive effect of creatine. Lean body mass (LBM) increased to a significantly greater extent with creatine. CONCLUSIONS / SIGNIFICANCE: Resistance exercise improved muscle size, strength and function in HIV-infected men. While creatine supplementation produced a greater increase in LBM, it did not augment the robust increase in strength derived from PRT.

Trial registration: ClinicalTrials.gov NCT00484627.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. CONSORT Diagram showing the disposition…
Figure 1. CONSORT Diagram showing the disposition of subjects randomized to receive creatine monohydrate or an equivalent number of placebo capsules for 14 weeks.
Figure 2. Muscle strength before and after…
Figure 2. Muscle strength before and after 14 weeks of study.
Large rectangles represent the average values, while smaller rectangles individual data before and after creatine supplementation. Similarly, large circles represent the average values, while smaller circles individual data before and after placebo supplementation. Data are the sum of strength (1 RM) in 8 muscle groups in subjects randomized to receive creatine monohydrate or placebo. Strength increased significantly within each treatment group (P

References

    1. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36:S69–78.
    1. Shevitz AH, Wilson IB, McDermott AY, Spiegelman D, Skinner SC, et al. A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting. J Acquir Immune Defic Syndr. 2005;38:399–406.
    1. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med. 2000;133:348–355.
    1. Rigsby LW, Dishman RK, Jackson AW, Maclean GS, Raven PB. Effects of exercise training on men seropositive for the human immunodeficiency virus-1. Med Sci Sports Exerc. 1992;24:6–12.
    1. Lox CL, McAuley E, Tucker RS. Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population. Int J Behav Med. 1996;3:55–69.
    1. Bhasin S, Storer TW. Exercise regimens for men with HIV. Jama. 2000;284:175–176.
    1. Yarasheski KE, Tebas P, Stanerson B, Claxton S, Marin D, et al. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol. 2001;90:133–138.
    1. Roubenoff R, Wilson IB. Effect of resistance training on self-reported physical functioning in HIV infection. Med Sci Sports Exerc. 2001;33:1811–1817.
    1. Robinson FP, Quinn LT, Rimmer JH. Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study. Biol Res Nurs. 2007;8:177–185.
    1. Dolan SE, Frontera W, Librizzi J, Ljungquist K, Juan S, et al. Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med. 2006;166:1225–1231.
    1. Smith DA, Perry PJ. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids. Ann Pharmacother. 1992;26:520–528.
    1. Smith DA, Perry PJ. The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents. Ann Pharmacother. 1992;26:653–659.
    1. Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003;94:651–659.
    1. Mujika I, Padilla S. Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med. 1997;18:491–496.
    1. Kilduff LP, Vidakovic P, Cooney G, Twycross-Lewis R, Amuna P, et al. Effects of creatine on isometric bench-press performance in resistance-trained humans. Med Sci Sports Exerc. 2002;34:1176–1183.
    1. Gilliam JD, Hohzorn C, Martin D, Trimble MH. Effect of oral creatine supplementation on isokinetic torque production. Med Sci Sports Exerc. 2000;32:993–996.
    1. Izquierdo M, Ibanez J, Gonzalez-Badillo JJ, Gorostiaga EM. Effects of creatine supplementation on muscle power, endurance, and sprint performance. Med Sci Sports Exerc. 2002;34:332–343.
    1. Culpepper RM. Creatine supplementation: safe as steak? South Med J. 1998;91:890–892.
    1. Snow RJ, McKenna MJ, Selig SE, Kemp J, Stathis CG, et al. Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J Appl Physiol. 1998;84:1667–1673.
    1. Kinugasa R, Akima H, Ota A, Ohta A, Sugiura K, et al. Short-term creatine supplementation does not improve muscle activation or sprint performance in humans. Eur J Appl Physiol. 2004;91:230–237.
    1. Syrotuik DG, Bell GJ. Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res. 2004;18:610–617.
    1. Green AL, Hultman E, Macdonald IA, Sewell DA, Greenhaff PL. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol. 1996;271:E821–826.
    1. Hubal MJ, Gordish-Dressman H, Thompson PD, Price TB, Hoffman EP, et al. Variability in muscle size and strength gain after unilateral resistance training. Med Sci Sports Exerc. 2005;37:964–972.
    1. Kent-Braun JA, Ng AV. Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol. 2000;89:1072–1078.
    1. Kent-Braun JA, Ng AV, Doyle JW, Towse TF. Human skeletal muscle responses vary with age and gender during fatigue due to incremental isometric exercise. J Appl Physiol. 2002;93:1813–1823.
    1. Karatzaferi C, Giakas G, Ball D. Fatigue profile: a numerical method to examine fatigue in cycle ergometry. Eur J Appl Physiol Occup Physiol. 1999;80:508–510.
    1. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51:1106–1112.
    1. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. “Buffalo hump” in men with HIV-1 infection. Lancet. 1998;351:867–870.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
    1. Hespel P, Op't Eijnde B, Van Leemputte M, Urso B, Greenhaff PL, et al. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol. 2001;536:625–633.
    1. Volek JS, Ratamess NA, Rubin MR, Gomez AL, French DN, et al. The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur J Appl Physiol. 2004;91:628–637.
    1. Volek JS, Kraemer WJ, Bush JA, Boetes M, Incledon T, et al. Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J Am Diet Assoc. 1997;97:765–770.
    1. Smith SA, Montain SJ, Matott RP, Zientara GP, Jolesz FA, et al. Effects of creatine supplementation on the energy cost of muscle contraction: a 31P-MRS study. J Appl Physiol. 1999;87:116–123.
    1. Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol. 1994;266:E725–730.
    1. Earnest CP, Snell PG, Rodriguez R, Almada AL, Mitchell TL. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207–209.
    1. Kreider RB, Ferreira M, Wilson M, Grindstaff P, Plisk S, et al. Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc. 1998;30:73–82.
    1. Komura K, Hobbiebrunken E, Wilichowski EK, Hanefeld FA. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr Neurol. 2003;28:53–58.
    1. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997;20:1502–1509.
    1. Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res. 1995;30:413–418.
    1. Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology. 2004;62:1771–1777.
    1. Walter MC, Lochmuller H, Reilich P, Klopstock T, Huber R, et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology. 2000;54:1848–1850.
    1. Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, et al. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE. 2007;2:e991.
    1. Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1. Muscle Nerve. 2004;29:51–58.
    1. Kornblum C, Schroder R, Muller K, Vorgerd M, Eggers J, et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol. 2005;12:300–309.
    1. Walter MC, Reilich P, Lochmuller H, Kohnen R, Schlotter B, et al. Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study. J Neurol. 2002;249:1717–1722.
    1. Zange J, Kornblum C, Muller K, Kurtscheid S, Heck H, et al. Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies. Ann Neurol. 2002;52:126; author reply 126–127.
    1. Rawson ES, Clarkson PM, Price TB, Miles MP. Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects. Acta Physiol Scand. 2002;174:57–65.
    1. Derave W, Marescau B, Vanden Eede E, Eijnde BO, De Deyn PP, et al. Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans. J Appl Physiol. 2004;97:852–857.
    1. Murata H, Hruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem. 2000;275:20251–20254.
    1. Nolte LA, Yarasheski KE, Kawanaka K, Fisher J, Le N, et al. The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle. Diabetes. 2001;50:1397–1401.
    1. Sinnwell TM, Sivakumar K, Soueidan S, Jay C, Frank JA, et al. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy. J Clin Invest. 1995;96:126–131.
    1. Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268–280.
    1. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48–62.
    1. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145–1152.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera